A.i. Drug Discovery Platform Insilico Medicine Announces $255M In Series C Funding – Techcrunch

by techcrunch.com posted 1month ago 9 views
Insilico Medicine, an A.I-based platform for drug development and discovery announced $255 million in Series C financing on Tuesday. The massive round is reflective of a recent breakthrough for the company: proof that it’s A.I based platform can create a new target for a disease, develop a bespoke molecule to address it, and begin the […]

In this article

No tags related to this article.